Detection of prostate cancer in the PSA gray zone using prostate-specific antigen mass ratio combined with PI-RADS score
Background: The study aimed to assess the diagnostic performance of prostate-specific antigen mass ratio (PSAMR) in combination with the Prostate Imaging Reporting and Data System (PI-RADS) score for detecting prostate cancer (PCa) in patients presenting with mildly elevated prostate-specific ant...
Saved in:
Main Authors: | Weilin Li, Zhiqi Wang, Weihong Zhao, Gaobo Zhou, Miaomiao Peng, Zhicheng Su, Tao-Hsin Tung |
---|---|
Format: | Article |
Language: | English |
Published: |
MRE Press
2025-07-01
|
Series: | Journal of Men's Health |
Subjects: | |
Online Access: | https://oss.jomh.org/files/article/20250730-588/pdf/JOMH2025032102.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER
by: A. A. Gritskevich, et al.
Published: (2017-02-01) -
Capillary Blood for Prostate-specific Antigen Testing: The PSA-CAP Study
by: Martin Wallisch, et al.
Published: (2025-08-01) -
Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen
by: Zh. R. Cherkasova, et al.
Published: (2023-03-01) -
Magnetic resonance semiotics of prostate cancer according to the PI-RADS classification. The clinical diagnostic algorithm of a study
by: A. S. Korobkin, et al.
Published: (2016-03-01) -
PI-RADSv2.1 combined with PSA density for optimizing prostate biopsy decisions: a retrospective analysis
by: Yuchun Li, et al.
Published: (2025-07-01)